Literature DB >> 8070812

Bruton's tyrosine kinase is a key regulator in B-cell development.

D J Rawlings1, O N Witte.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8070812     DOI： 10.1111/j.1600-065x.1994.tb00849.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN： 0105-2896            Impact factor:   12.988


× No keyword cloud information.
  25 in total

Review 1.  The molecular pathology of primary immunodeficiencies.

Authors:  Megan S Lim; Kojo S J Elenitoba-Johnson
Journal:  J Mol Diagn       Date:  2004-05       Impact factor: 5.568

2.  A novel Tth111I restriction fragment length polymorphism (RFLP) allows tracing of X-chromosome inactivation in the (Xid) heterozygote.

Authors:  V Shanmugam; V M Chapman; K W Sell; B K Saha
Journal:  Biochem Genet       Date:  1996-02       Impact factor: 1.890

3.  Correction of the X-linked immunodeficiency phenotype by transgenic expression of human Bruton tyrosine kinase under the control of the class II major histocompatibility complex Ea locus control region.

Authors:  D Drabek; S Raguz; T P De Wit; G M Dingjan; H F Savelkoul; F Grosveld; R W Hendriks
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

Review 4.  Back to the future: oral targeted therapy for RA and other autoimmune diseases.

Authors:  John J O'Shea; Arian Laurence; Iain B McInnes
Journal:  Nat Rev Rheumatol       Date:  2013-02-19       Impact factor: 20.543

Review 5.  Midkine as a regulator of B cell survival in health and disease.

Authors:  Sivan Cohen; Idit Shachar
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

6.  TSLP signaling network revealed by SILAC-based phosphoproteomics.

Authors:  Jun Zhong; Min-Sik Kim; Raghothama Chaerkady; Xinyan Wu; Tai-Chung Huang; Derese Getnet; Christopher J Mitchell; Shyam M Palapetta; Jyoti Sharma; Robert N O'Meally; Robert N Cole; Akinori Yoda; Albrecht Moritz; Marc M Loriaux; John Rush; David M Weinstock; Jeffrey W Tyner; Akhilesh Pandey
Journal:  Mol Cell Proteomics       Date:  2012-02-16       Impact factor: 5.911

7.  Transcriptional activation of a ras-like gene (kir) by oncogenic tyrosine kinases.

Authors:  L Cohen; R Mohr; Y Y Chen; M Huang; R Kato; D Dorin; F Tamanoi; A Goga; D Afar; N Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

8.  Macrophages eat cancer cells using their own calreticulin as a guide: roles of TLR and Btk.

Authors:  Mingye Feng; James Y Chen; Rachel Weissman-Tsukamoto; Jens-Peter Volkmer; Po Yi Ho; Kelly M McKenna; Samuel Cheshier; Michael Zhang; Nan Guo; Phung Gip; Siddhartha S Mitra; Irving L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

9.  Clinical features and mutation analysis of X-linked agammaglobulinemia in 20 Chinese patients.

Authors:  Xian Qin; Li-Ping Jiang; Xue-Mei Tang; Mo Wang; En-Mei Liu; Xiao-Dong Zhao
Journal:  World J Pediatr       Date:  2013-01-18       Impact factor: 2.764

10.  B cell-specific lentiviral gene therapy leads to sustained B-cell functional recovery in a murine model of X-linked agammaglobulinemia.

Authors:  Hannah M Kerns; Byoung Y Ryu; Brigid V Stirling; Blythe D Sather; Alexander Astrakhan; Stephanie Humblet-Baron; Denny Liggitt; David J Rawlings
Journal:  Blood       Date:  2010-01-21       Impact factor: 22.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.